Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Theravance Biopharma Debt to Equity Ratio 2012-2024 | TBPH

Current and historical debt to equity ratio values for Theravance Biopharma (TBPH) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Theravance Biopharma debt/equity for the three months ending December 31, 2024 was 0.00.
  
Theravance Biopharma Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-12-31 $0.18B $0.18B 1.02
2024-09-30 $0.17B $0.19B 0.92
2024-06-30 $0.17B $0.19B 0.87
2024-03-31 $0.17B $0.21B 0.81
2023-12-31 $0.17B $0.21B 0.79
2023-09-30 $0.17B $0.25B 0.68
2023-06-30 $0.17B $0.28B 0.59
2023-03-31 $0.17B $0.37B 0.45
2022-12-31 $0.17B $0.44B 0.38
2022-09-30 $0.28B $0.48B 0.59
2022-06-30 $0.71B $-0.35B -2.03
2022-03-31 $0.71B $-0.35B -2.01
2021-12-31 $0.71B $-0.34B -2.11
2021-09-30 $0.73B $-0.32B -2.25
2021-06-30 $0.73B $-0.30B -2.43
2021-03-31 $0.75B $-0.37B -2.01
2020-12-31 $0.77B $-0.30B -2.54
2020-09-30 $0.77B $-0.26B -2.96
2020-06-30 $0.77B $-0.20B -3.79
2020-03-31 $0.76B $-0.16B -4.83
2019-12-31 $0.63B $-0.22B -2.83
2019-09-30 $0.63B $-0.18B -3.44
2019-06-30 $0.63B $-0.14B -4.59
2019-03-31 $0.65B $-0.11B -5.69
2018-12-31 $0.61B $-0.05B -11.86
2018-09-30 $0.38B $-0.01B -28.59
2018-06-30 $0.39B $0.03B 11.25
2018-03-31 $0.42B $0.06B 6.57
2017-12-31 $0.33B $0.12B 2.83
2017-09-30 $0.30B $0.18B 1.64
2017-06-30 $0.30B $0.24B 1.26
2017-03-31 $0.29B $0.29B 1.00
2016-12-31 $0.29B $0.35B 0.83
2016-09-30 $0.06B $0.30B 0.20
2016-06-30 $0.05B $0.32B 0.17
2016-03-31 $0.06B $0.24B 0.23
2015-12-31 $0.06B $0.24B 0.24
2015-09-30 $0.04B $0.22B 0.16
2015-06-30 $0.03B $0.26B 0.12
2015-03-31 $0.04B $0.29B 0.12
2014-12-31 $0.05B $0.29B 0.17
2014-09-30 $0.04B $0.34B 0.12
2014-06-30 $0.05B $0.39B 0.12
2014-03-31 $0.04B $-0.02B -2.46
2013-12-31 $0.04B $-0.02B -2.48
2013-09-30 $0.00B $0.00B 0.00
2013-06-30 $0.00B $0.00B 0.00
2013-03-31 $0.00B $0.00B 0.00
2012-12-31 $0.03B $-0.01B -4.00
2011-12-31 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.457B $0.064B
Theravance Biopharma is a biopharmaceutical company primarily focused on discovering, developing and commercializing respiratory medicines. The company was formed following the split of the erstwhile Theravance into two listed companies in June 2014 - Innoviva, Inc. (then Theravance, Inc.) and Theravance.?
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $84.579B 31.73
Zoetis (ZTS) United States $71.389B 26.64
Takeda Pharmaceutical (TAK) Japan $44.547B 8.86
Daiichi Sankyo, - (DSNKY) Japan $44.407B 22.59
Sandoz Group AG (SDZNY) Switzerland $20.218B 0.00
Summit Therapeutics (SMMT) United States $17.148B 0.00
Merck (MKKGY) Germany $16.879B 12.37
United Therapeutics (UTHR) United States $13.709B 12.13
Shionogi (SGIOY) Japan $12.740B 12.76
Neurocrine Biosciences (NBIX) United States $11.903B 40.77
IPSEN (IPSEY) France $9.572B 0.00
Orion OYJ (ORINY) Finland $8.544B 23.11
Corcept Therapeutics (CORT) United States $7.779B 63.24
Stevanato Group S.p.A (STVN) Italy $7.062B 43.19
Madrigal Pharmaceuticals (MDGL) United States $6.479B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.976B 0.00
Grifols, S.A (GRFS) Spain $5.397B 0.00
Ionis Pharmaceuticals (IONS) United States $5.251B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.040B 15.33
Soleno Therapeutics (SLNO) United States $3.783B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.922B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.901B 10.16
Hypermarcas (HYPMY) Brazil $2.869B 18.88
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.351B 12.71
BioCryst Pharmaceuticals (BCRX) United States $2.136B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.054B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.728B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.682B 0.00
Guardian Pharmacy Services (GRDN) United States $1.577B 0.00
Indivior (INDV) United States $1.526B 6.47
Evotec AG (EVO) Germany $1.399B 0.00
Dyne Therapeutics (DYN) United States $1.334B 0.00
ARS Pharmaceuticals (SPRY) United States $1.198B 0.00
Ocular Therapeutix (OCUL) United States $1.142B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.101B 22.03
Collegium Pharmaceutical (COLL) United States $0.943B 5.08
Harrow (HROW) United States $0.940B 0.00
Enliven Therapeutics (ELVN) United States $0.874B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.860B 0.00
Ardelyx (ARDX) United States $0.809B 0.00
Cronos Group (CRON) Canada $0.802B 0.00
Xeris Biopharma Holdings (XERS) United States $0.749B 0.00
AleAnna (ANNA) United States $0.700B 0.00
Akebia Therapeutics (AKBA) United States $0.667B 0.00
Xencor (XNCR) United States $0.584B 0.00
KalVista Pharmaceuticals (KALV) United States $0.580B 0.00
USANA Health Sciences (USNA) United States $0.559B 12.15
Regulus Therapeutics (RGLS) United States $0.543B 0.00
Savara (SVRA) United States $0.538B 0.00
Bioventus (BVS) United States $0.537B 13.62
CytoDyn (CYDY) United States $0.505B 0.00
Elite Pharmaceuticals (ELTP) United States $0.482B 0.00
Relay Therapeutics (RLAY) United States $0.478B 0.00
Altimmune (ALT) United States $0.469B 0.00
Zevra Therapeutics (ZVRA) United States $0.461B 0.00
Siga Technologies (SIGA) United States $0.423B 8.84
Amylyx Pharmaceuticals (AMLX) United States $0.403B 0.00
Tourmaline Bio (TRML) United States $0.399B 0.00
Verve Therapeutics (VERV) United States $0.385B 0.00
Organogenesis (ORGO) United States $0.384B 0.00
Oruka Therapeutics (ORKA) United States $0.354B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.353B 9.54
Heron Therapeutics (HRTX) United States $0.285B 0.00
Nature's Sunshine Products (NATR) United States $0.270B 24.90
ProKidney (PROK) United States $0.249B 0.00
Aquestive Therapeutics (AQST) United States $0.236B 0.00
MediWound (MDWD) Israel $0.216B 0.00
OmniAb (OABI) United States $0.189B 0.00
Nanobiotix S.A (NBTX) France $0.173B 0.00
Liminatus Pharma (LIMN) $0.172B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.169B 0.00
Avita Medical (RCEL) United States $0.168B 0.00
Wellgistics Health (WGRX) United States $0.167B 0.00
Journey Medical (DERM) United States $0.164B 0.00
Esperion Therapeutics (ESPR) United States $0.154B 0.00
Inhibikase Therapeutics (IKT) United States $0.151B 0.00
4D Molecular Therapeutics (FDMT) United States $0.148B 0.00
Profound Medical (PROF) Canada $0.136B 0.00
Korro Bio (KRRO) United States $0.136B 0.00
Aclaris Therapeutics (ACRS) United States $0.132B 0.00
Aldeyra Therapeutics (ALDX) United States $0.129B 0.00
Nektar Therapeutics (NKTR) United States $0.127B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Protara Therapeutics (TARA) United States $0.120B 0.00
Larimar Therapeutics (LRMR) United States $0.120B 0.00
Lyell Immunopharma (LYEL) United States $0.119B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.115B 0.00
Cassava Sciences (SAVA) United States $0.099B 0.00
VAXART, INC (VXRT) United States $0.097B 0.00
OptiNose (OPTN) United States $0.096B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.096B 0.00
Achieve Life Sciences (ACHV) Canada $0.095B 0.00
Cardiol Therapeutics (CRDL) Canada $0.094B 0.00
Lexeo Therapeutics (LXEO) United States $0.090B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.088B 0.00
Champions Oncology (CSBR) United States $0.087B 14.27
Galectin Therapeutics (GALT) United States $0.083B 0.00
Dominari Holdings (DOMH) United States $0.082B 0.00
Fractyl Health (GUTS) United States $0.081B 0.00
Arch Biopartners (ACHFF) Canada $0.080B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.078B 58.22
ESSA Pharma (EPIX) Canada $0.076B 0.00
Telomir Pharmaceuticals (TELO) United States $0.070B 0.00
Inotiv (NOTV) United States $0.070B 0.00
Pyxis Oncology (PYXS) United States $0.069B 0.00
Context Therapeutics (CNTX) United States $0.067B 0.00
Unicycive Therapeutics (UNCY) United States $0.066B 0.00
Nutriband (NTRB) United States $0.062B 0.00
Assertio Holdings (ASRT) United States $0.061B 0.00
Vivani Medical (VANI) United States $0.061B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.059B 0.00
Surrozen (SRZN) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Metagenomi (MGX) United States $0.058B 0.00
Gain Therapeutics (GANX) United States $0.054B 0.00
Prelude Therapeutics (PRLD) United States $0.053B 0.00
Karyopharm Therapeutics (KPTI) United States $0.047B 0.00
Century Therapeutics (IPSC) United States $0.045B 0.00
Mural Oncology (MURA) Ireland $0.044B 0.00
PMV Pharmaceuticals (PMVP) United States $0.044B 0.00
Avalo Therapeutics (AVTX) United States $0.042B 0.00
NRx Pharmaceuticals (NRXP) United States $0.041B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.039B 0.00
SCYNEXIS (SCYX) United States $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
ElectroCore (ECOR) United States $0.037B 0.00
Rafael Holdings (RFL) United States $0.036B 0.00
Acrivon Therapeutics (ACRV) United States $0.034B 0.00
FibroGen (FGEN) United States $0.031B 0.00
PolyPid (PYPD) Israel $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Tempest Therapeutics (TPST) United States $0.024B 0.00
CASI Pharmaceuticals (CASI) China $0.022B 0.00
Mannatech (MTEX) United States $0.021B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
Jupiter Neurosciences (JUNS) United States $0.020B 0.00
Lipocine (LPCN) United States $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
DURECT (DRRX) United States $0.019B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Vivos Therapeutics (VVOS) United States $0.018B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.016B 0.00
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
Relmada Therapeutics (RLMD) United States $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.011B 1.90
BioLineRx (BLRX) Israel $0.010B 0.00
Talphera (TLPH) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Plus Therapeutics (PSTV) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Ainos (AIMD) United States $0.008B 0.00
Citius Pharmaceuticals (CTXR) United States $0.008B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Carisma Therapeutics (CARM) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Traws Pharma (TRAW) United States $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
Klotho Neurosciences (KLTO) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Incannex Healthcare (IXHL) Australia $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
SHINECO (SISI) China $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00